Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Wanbury Limited ( (IN:WANBURY) ) just unveiled an announcement.
Wanbury Limited has reported to the NSE and BSE the voting results of its Extraordinary General Meeting held on 5 January 2026, in compliance with SEBI’s Listing Obligations and Disclosure Requirements. The company disclosed shareholder participation figures, including total shareholders on record and attendance via video conferencing by promoter group and public shareholders, and submitted the scrutinizer’s report from an independent practicing company secretary, underscoring its adherence to prescribed corporate governance and disclosure norms.
More about Wanbury Limited
Wanbury Limited is an India-based pharmaceutical company headquartered in Navi Mumbai, Maharashtra, and listed on both the National Stock Exchange of India and BSE. The company operates in the healthcare and life sciences sector, focusing on the manufacture and sale of pharmaceutical products for domestic and international markets.
Average Trading Volume: 5,685
Technical Sentiment Signal: Buy
Current Market Cap: 8.21B INR
See more data about WANBURY stock on TipRanks’ Stock Analysis page.